Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes

Anyanwagu, U; Mamza, J; Mehta, R; Donnelly, R; Idris, I; (2016) Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes. Heart (British Cardiac Society), 102 (19). pp. 1581-7. ISSN 1355-6037 DOI: https://doi.org/10.1136/heartjnl-2015-309164

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/heartjnl-2015-309164

Abstract

Share

Download

Filename: Cardiovascular events and all-cause mortality_GREEN AAM.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar